S.T.Japan-USA, LLC Company Profile

00:17 EDT 23rd September 2018 | BioPortfolio

S.T. Japan USA, LLC is the American branch of S.T. Japan, Inc. . It is a member of the S.T. Japan Group.
Our main functions and activities are:
To directly sell to End-Users located in the USA and the other Americas, products developed and produced by S.T. Japan, Inc. and other Japanese manufacturers represented by S.T.Japan, Inc. .
Our Key Products are:
- Spectra Databases
- Spectroscopic Accessories
- Microscopy Accessories
- Analytical Instruments
To establish distribution arrangements with companies in the Americas desiring to distribute S.T. Japan, Inc. products or products of other Japanese manufacturers represented by S.T. Japan, Inc. Please contact us if you would be interested in such an arrangement.
To seek companies desiring distribution in Japan and Korea. To help locate and identify companies throughout the world, with new and innovative analytical, process and biochemical instrumentation or accessories, that are seeking distribution in Japan and Korea.


8813 East Bay Circle
Ft. Myers
United States of America


Phone: 1 239-267-3676
Fax: 1 866-476-0468

News Articles [291 Associated News Articles listed on BioPortfolio]

Interphex Japan to to be held at Tokyo Big Sight from June 27 to 29

Interphex Japan, Asia's leading trade show for pharmaceutical R&D to manufacturing and in─PHARMA Japan along with co─held shows BIOtech Japan and BioPharma Expo will be held at Tokyo Big Sight, Ja...

JBA: Setsuo Morishita on the History of JBA, and Biotechnology in Japan

In this episode of PharmaTelevision News Review, Fintan Walton talks to Setsuo Morishita, Deputy Director of Japan Bioindustry Association, about the History of JBA. They discuss: • Growth of Biote...

Report: Apple Probed In Japan Over Anti-competitive Behavior

CUPERTINO (dpa-AFX) - Japan is investigating allegations that pressure from Apple forced Yahoo Japan to pull back from a game platform that competes with the App Store, Nikkei Asian review reporte...

Pricing system reform and generics trend apparent at CPhI Japan 2018

After recent changes in Japan, which is known to be an innovative drug market, an increase in international generic API companies and suppliers has been reported at next month s CPhI Japan 2018

New-drug application filed in Japan for Etanercept biosimilar

YL Biologics, a joint venture between India's Lupin and Japan's Yoshindo, filed a new-drug application in Japan for its Entar -More- 

CPhI Japan

18–20 April 2018 | Exhibition | Tokyo, Japan

BRIEF—YLB moves ahead with filing for biosimilar Enbrel in Japan

YL Biologics, a joint venture between Japan’s Yoshindo and India’s Lupin says the Japanese medicines…

Shallow quakes shake parts of western Japan, more tremors expected

A series of shallow earthquakes shook parts of western Japan on Monday and authorities warned that further strong shaking is possible over the coming days. A quake at 1632 GMT measured at magnitude 5...

PubMed Articles [493 Associated PubMed Articles listed on BioPortfolio]

Epidemiological observations of Kawasaki disease in Japan, 2013-2014.

The etiology of Kawasaki disease (KD) is unknown. In Japan, the number of patients and incidence rate of KD has increased continuously since its discovery. This report aimed to analyze the latest nati...

Introduction of laryngeal mask airway in Japan, and its rescue use for newborns.

In neonatal resuscitation, laryngeal mask airway (LMA) is recommended when both face mask ventilation and endotracheal intubation fail. However, experience of LMA among obstetricians, nurses and midwi...

Nepalese migrants in Japan: What is holding them back in getting access to healthcare?

Migrants are one of the most deprived and vulnerable groups who receive the least health services in the society. Only a few studies have been conducted on access to healthcare among migrants in Asia,...

Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan.

The Research Group on Chemotherapy of Tropical Diseases, Japan, introduced artemether-lumefantrine (AL) in late 2002, mainly for treating uncomplicated Plasmodium falciparum malaria. Because AL was on...

Hemoglobin Seattle detection based on low capillary oxygen saturation: First reported case in Japan.

Clinical Trials [345 Associated Clinical Trials listed on BioPortfolio]

Clinical Characteristics and Practice Patterns of T2DM Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

Appropriate use of oral antidiabetic drugs (OADs) including dose-reduction is important for patient's safety in T2DM patients with renal impairment (RI). However, there are insufficient da...

GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)

The purpose of this study is to evaluate the safety and tolerability of AVE0010 once daily treatment in monotherapy in type 2 diabetes patients in Japan over 76 weeks of treatment. The pr...

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinica...

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

The purpose of this study is to compare the effects of pitavastatin and atorvastatin on coronary plaque volume in patients with acute coronary syndrome and to clarify the relationship betw...

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

The purpose of this post-marketing survey is to obtain real-world information on the safety and effectiveness of evolocumab in Japan.

Companies [426 Associated Companies listed on BioPortfolio]

S.T.Japan-USA, LLC

S.T. Japan USA, LLC is the American branch of S.T. Japan, Inc. . It is a member of the S.T. Japan Group. Our main functions and activities are:To directly sell to End-Users located in the USA and the ...

Japan Prize Foundation

Since its inception in 1985, the Japan Prize Foundation has awarded the Japan Prize to 70 people from 13 countries. In addition to awarding the Japan Prize, which is endorsed by t...

CMP Japan Group

As a leading business-to business media and market information company, The CMP Japan Group's activities encompass trade shows, publishing, conferences and seminars . We are engaged in a wide range of...

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem c...

The Ministry of Agriculture, Forestry and Fisheries of Japan

More Information about "S.T.Japan-USA, LLC" on BioPortfolio

We have published hundreds of S.T.Japan-USA, LLC news stories on BioPortfolio along with dozens of S.T.Japan-USA, LLC Clinical Trials and PubMed Articles about S.T.Japan-USA, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of S.T.Japan-USA, LLC Companies in our database. You can also find out about relevant S.T.Japan-USA, LLC Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record